1. Home
  2. FDBC vs CNTX Comparison

FDBC vs CNTX Comparison

Compare FDBC & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidelity D & D Bancorp Inc.

FDBC

Fidelity D & D Bancorp Inc.

HOLD

Current Price

$43.75

Market Cap

262.3M

Sector

Finance

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$2.91

Market Cap

283.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FDBC
CNTX
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.3M
283.9M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
FDBC
CNTX
Price
$43.75
$2.91
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$6.00
AVG Volume (30 Days)
3.9K
895.0K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.93%
N/A
EPS Growth
35.00
69.33
EPS
4.86
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.00
$0.49
52 Week High
$50.00
$3.62

Technical Indicators

Market Signals
Indicator
FDBC
CNTX
Relative Strength Index (RSI) 46.04 56.23
Support Level $42.09 $2.07
Resistance Level $45.89 N/A
Average True Range (ATR) 1.19 0.30
MACD -0.07 -0.00
Stochastic Oscillator 37.33 52.27

Price Performance

Historical Comparison
FDBC
CNTX

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: